This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Zacks Industry Outlook Highlights MSCI, Tyler Technologies, Guidewire Software and ePlus
by Zacks Equity Research
MSCI, Tyler Technologies, Guidewire Software and ePlus are part of the Zacks Industry Outlook article.
4 Stocks to Watch From the Prospering Business-Software Services Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, GWRE and PLUS are poised to benefit from the robust demand trend for multi-cloud-enabled software solutions.
EPlus (PLUS) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of -14.49% and 14.91%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights Dream Finders Homes, Worthington and ePlus
by Zacks Equity Research
Dream Finders Homes, Worthington and ePlus have been highlighted in this Screen of The Week article.
New Analyst Coverage: 3 Stocks in Focus for Higher Returns
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as Dream Finders Homes (DFH), Worthington (WOR) and ePlus (PLUS) indicates the potential for significant price appreciation in the near term.
Zacks Investment Ideas feature highlights: AppLovin, Nvidia, Vertiv Holdings and ePlus
by Zacks Equity Research
AppLovin, Nvidia, Vertiv Holdings and ePlus are part of the Zacks Investment Ideas article.
3 Top-Ranked Tech Stocks Crushing the Market to Buy in Q4
by Benjamin Rains
Diving into top-ranked Zacks stocks from the tech sector that have crushed the market in 2023--two are even attempting to keep pace with Nvidia's 200% rally. All three stocks also offer nice growth outlooks and appear to be sitting at solid technical levels.
Get a Buoyant Portfolio With These 5 Low Price-to-Sales Stocks
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like TITN, MFIN, PLUS, CRAI and PAGP hold promise.
Is ePlus (PLUS) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how ePlus (PLUS) and Synopsys (SNPS) have performed compared to their sector so far this year.
Boost Portfolio Gains With These 5 Low Price-to-Sales Stocks
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like KBH, MFIN, PLUS, CRAI and PAGS hold promise.
ePlus (PLUS) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, ePlus (PLUS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks.com featured highlights KB Home, Medallion Financial, ePlus, Charles River and PagSeguro Digital
by Zacks Equity Research
KB Home, Medallion Financial, ePlus, Charles River and PagSeguro Digital have been highlighted in this Screen of The Week article.
Intriguing Tech Stocks to Buy for a Market Rebound
by Shaun Pruitt
Opening on a higher note this week, the Nasdaq was up over 1% again today and a rebound appears to be building after weeks of volatility.
5 Low Price-to-Sales Stocks to Get the Best of the Market
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like KBH, MFIN, PLUS, CRAI and PAGS hold promise.
What Makes ePlus (PLUS) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does ePlus (PLUS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Industry Outlook Highlights MSCI, Tyler Technologies, Guidewire Software and ePlus
by Zacks Equity Research
MSCI, Tyler Technologies, Guidewire Software and ePlus are part of the Zacks Industry Outlook article.
4 Business-Software Services Stocks to Watch in a Prospering Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, GWRE and PLUS are poised to benefit from the robust demand trend for multi-cloud-enabled software solutions.
Fight August Volatility With 'Strong Buy' Stocks Trading Near Highs
by Benjamin Rains
Investors likely want to search for stocks that have boosted their earnings outlooks recently and are still trading near their highs through the somewhat rocky start to August...
Best Momentum Stocks to Buy for August 14th
by Zacks Equity Research
PLUS, KRT and FDUS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 14, 2023.
EPlus (PLUS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of 42.42% and 17.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 13.40% and 1.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Low Price-to-Sales Stocks That Promise Lucrative Returns
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like CRUS, PLUS, GIII, JAKK and UFPI hold promise.
5 Low Price-to-Sales Stocks to Keep Your Investments Safe
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, GIII, PAM and UFPI hold promise.
Fast-paced Momentum Stock ePlus (PLUS) Is Still Trading at a Bargain
by Zacks Equity Research
ePlus (PLUS) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Cognizant (CTSH) Partners With Accuray to Improve Healthcare
by Zacks Equity Research
Cognizant's (CTSH) partnership agreement will enable Accuray to streamline and drive operational changes to improve patient care.